Humoral epitope spreading in autoimmune bullous diseases
D Didona, G Di Zenzo - Frontiers in immunology, 2018 - frontiersin.org
Autoimmune blistering diseases are characterized by autoantibodies against structural
adhesion proteins of the skin and mucous membranes. Extensive characterization of their …
adhesion proteins of the skin and mucous membranes. Extensive characterization of their …
Linear immunoglobulin A bullous dermatosis
G Fortuna, MP Marinkovich - Clinics in dermatology, 2012 - Elsevier
Linear immunoglobulin A (IgA) bullous dermatosis, also known as linear IgA disease, is an
autoimmune mucocutaneous disorder characterized by subepithelial bullae, with IgA …
autoimmune mucocutaneous disorder characterized by subepithelial bullae, with IgA …
Linear immunoglobulin a bullous dermatosis: need for an agreement on diagnostic criteria
E Antiga, M Caproni, P Fabbri - Dermatology, 2013 - karger.com
Linear immunoglobulin A bullous dermatosis (LABD) is a rare, heterogeneous, autoimmune
blistering disorder. Although the main characteristics of the disease seem to be well …
blistering disorder. Although the main characteristics of the disease seem to be well …
Immunobullous diseases
F Wojnarowska, VA Venning - Rook's Textbook of dermatology, 2010 - Wiley Online Library
This chapter deals with the autoimmune blistering diseases The molecular mechanisms
underpinning the structural integrity of the epidermis and its attachment to the dermis are …
underpinning the structural integrity of the epidermis and its attachment to the dermis are …
Recombinant human IgA1 and IgA2 autoantibodies to type VII collagen induce subepidermal blistering ex vivo
A Recke, LM Trog, HH Pas, A Vorobyev… - The Journal of …, 2014 - journals.aai.org
Subepidermal autoimmune blistering dermatoses (AIBD) are prototypic autoantibody-
mediated diseases. In epidermolysis bullosa acquisita (EBA), an autoimmune disease with …
mediated diseases. In epidermolysis bullosa acquisita (EBA), an autoimmune disease with …
Linear IgA/IgG bullous dermatosis reacts with multiple laminins and integrins
X Li, A Tsuchisaka, H Qian, K Teye, N Ishii… - European Journal of …, 2015 - Springer
Background Since the original description by Zone et al in 1994, the disease entity and
target antigens in linear IgA/IgG bullous dermatosis (LAGBD) have not been clarified in 20 …
target antigens in linear IgA/IgG bullous dermatosis (LAGBD) have not been clarified in 20 …
[HTML][HTML] Immunologic overlap in a case of linear IgG/IgA bullous dermatosis responsive to rituximab
D Nedosekin, KD Wilson, K Campbell, S Shalin… - JAAD case …, 2021 - Elsevier
Autoimmune subepidermal blistering diseases are caused by immunological loss of
tolerance to components of hemidesmosomes, triggering humoral and cellular responses. 1 …
tolerance to components of hemidesmosomes, triggering humoral and cellular responses. 1 …
[PDF][PDF] Botulinum Toxin A: An Effective Treatment for Linear Immunoglobulin A Bullous Dermatosis Located in the Axillae.
L Legendre, A Maza, A Almalki… - Acta Dermato …, 2016 - researchgate.net
DISCUSSION This case report demonstrates the efficacy of BtxA injections for LABD in the
axillae, and shows a marked decrease in the number of blisters, pain, sweating, global …
axillae, and shows a marked decrease in the number of blisters, pain, sweating, global …
Linear IgA/IgG bullous dermatosis: successful treatment with dapsone and mycophenolate mofetil
L Passos, RF Rabelo, C Matsuo, M Santos… - Anais Brasileiros de …, 2011 - SciELO Brasil
A 21-year-old female presenting linear IgA and IgG disease initially responded well to
dapsone therapy. However, the treatment with dapsone was withdrawn due to severe …
dapsone therapy. However, the treatment with dapsone was withdrawn due to severe …
Linear IgA/IgG bullous dermatosis after nivolumab therapy.
H Perandones‐González… - International …, 2021 - search.ebscohost.com
However, in drug-induced cases, eosinophils can be the predominant cell. 4 Few reports on
either BP or LABD featuring dual IgG and IgA anti-basement membrane antibody …
either BP or LABD featuring dual IgG and IgA anti-basement membrane antibody …